Suppression of experimental autoimmune encephalomyelitis by ghrelin. 2009

Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
Department of Immunology, National Institute of Neuroscience, National Centre of Neurology and Psychiatry, Tokyo, Japan.

Ghrelin is a recently identified gastric hormone that displays strong growth hormone-releasing activity mediated by the growth hormone secretagogue receptor. While this unique endogenous peptide participates in the regulation of energy homeostasis, increases food intake, and decreases energy expenditure, its ability to inhibit the production of proinflammatory cytokines in vitro indicates its role in the regulation of inflammatory process in vivo. Here we examine the effect of exogenous ghrelin on the development of experimental autoimmune encephalomyelitis (EAE), a representative model of multiple sclerosis. In the C57BL/6 mouse model of EAE induced by sensitization to myelin oligodendrocyte glycoprotein 35-55 peptide, we found that alternate-day s.c. injections of ghrelin (5 mug/kg/day) from day 1 to 35 significantly reduced the clinical severity of EAE. The suppression of EAE was accompanied by reduced mRNA levels of proinflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6 in the spinal cord cellular infiltrates and microglia from ghrelin-treated mice at the peak of disease, suggesting the role of ghrelin as an antiinflammatory hormone. Consistently, ghrelin significantly suppressed the production of proinflammatory cytokines in LPS-stimulated microglia in vitro. These results shed light on the new role of ghrelin in the regulation of inflammation with possible implications for management of human diseases.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
January 1994, Immunopharmacology,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
August 1989, The New England journal of medicine,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
March 1990, Acta neurologica Scandinavica,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
December 1999, Cellular immunology,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
July 1992, Journal of neuroimmunology,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
February 2021, Journal of immunology (Baltimore, Md. : 1950),
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
December 1998, Experimental neurology,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
May 2007, Autoimmunity,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
August 2013, Archives of biochemistry and biophysics,
Michael-Mark Theil, and Sachiko Miyake, and Miho Mizuno, and Chiharu Tomi, and J Ludovic Croxford, and Hiroshi Hosoda, and Julia Theil, and Stephan von Hörsten, and Hiroaki Yokote, and Asako Chiba, and Youwei Lin, and Shinji Oki, and Takashi Akamizu, and Kenji Kangawa, and Takashi Yamamura
April 1993, Journal of neuroimmunology,
Copied contents to your clipboard!